Other Stories

U.S. FDA approves S. Korea's Celltrion COVID-19 test kit Updated: 2020-10-27 10:53:03 KST

South Korean pharmaceutical company Celltrion has received emergency use authorization from the U.S. FDA for its rapid COVID-19 test kit.
The approval comes three months after the initial requestand with U.S. recording its highest daily case totals over the past two days.
The kit can deliver test results within ten minutes and with 94 percent accuracy.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.